Pharm prime vendor fleet
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DX25D9800
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Last date to order 16% complete
- IDV ceiling
- $0.01
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain division on March 7, 2025, to serve as a Pharmaceutical Prime Vendor under the Global Program Generation V initiative. The contract, which carries a ceiling value of zero dollars as currently documented, has an ultimate completion date of March 6, 2035, and is structured with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group will provide worldwide pharmaceutical support to Department of Defense military healthcare facilities, delivering a comprehensive portfolio of products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The contract operates on a firm fixed-price delivery order basis, with the company's product offerings encompassing oncology treatments, immunosuppressants, emergency medications, specialty surgical products, contraceptive devices, and routine pharmaceuticals across multiple therapeutic categories.
The underlying solicitation, posted as a pre-solicitation notice on February 1, 2024, established the Pharmaceutical Prime Vendor Global Program Generation V as a $30.3 billion acquisition strategy intended to make multiple regional awards across distinct geographic lines of business including North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet operations. The Defense Logistics Agency anticipated awarding contracts to at least three different contractors on a regional basis, with both primary and backup suppliers required to provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally. No set-aside was designated for this procurement, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. The contract enables the Defense Logistics Agency to issue delivery orders for recurring pharmaceutical supply needs to support Department of Defense healthcare operations worldwide, with pricing structured around distribution fees rather than product markups, ensuring cost-effective provision of critical pharmaceutical products to military medical facilities.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract SPE2DX25D9800?
SPE2DX25D9800 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on March 7, 2025.
How much is contract SPE2DX25D9800 worth?
SPE2DX25D9800's own ceiling is $0.
Who can order from contract SPE2DX25D9800?
SPE2DX25D9800 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DX25D9800 competed?
The extent of competition for SPE2DX25D9800 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV